An Interferon-Related Signature in the Transcriptional Core Response of Human Macrophages to Mycobacterium tuberculosis Infection by Wu, Kang et al.
An Interferon-Related Signature in the Transcriptional
Core Response of Human Macrophages to
Mycobacterium tuberculosis Infection
Kang Wu
1,2., Dandan Dong
3., Hai Fang
1,2., Florence Levillain
4,5., Wen Jin
1, Jian Mei
6, Brigitte Gicquel
7,
Yanzhi Du
2, Kankan Wang
1, Qian Gao
3, Olivier Neyrolles
4,5*, Ji Zhang
1,2*
1State Key Laboratory of Medical Genomics and Sino-French Research Center for Life Sciences and Genomics, Ruijin Hospital affiliated to Shanghai Jiao Tong University
School of Medicine, Shanghai, China, 2Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences/Shanghai Jiao Tong
University School of Medicine, Shanghai, China, 3Key Laboratory of Medical Molecular Virology, Shanghai Medical College, Fudan University, Shanghai, China, 4Centre
National de la Recherche Scientifique, Institut de Pharmacologie et de Biologie Structurale, Toulouse, France, 5Universite ´ de Toulouse, Universite ´ Paul Sabatier, Institut de
Pharmacologie et de Biologie Structurale, Toulouse, France, 6Department of Tuberculosis Control, Shanghai Municipal CDC, Shanghai, China, 7Unite ´ de Ge ´ne ´tique
Mycobacte ´rienne, Institut Pasteur, Paris, France
Abstract
The W-Beijing family of Mycobacterium tuberculosis (Mtb) strains is known for its high-prevalence and -virulence, as well as
for its genetic diversity, as recently reported by our laboratories and others. However, little is known about how the immune
system responds to these strains. To explore this issue, here we used reverse engineering and genome-wide expression
profiling of human macrophage-like THP-1 cells infected by different Mtb strains of the W-Beijing family, as well as by the
reference laboratory strain H37Rv. Detailed data mining revealed that host cell transcriptome responses to H37Rv and to
different strains of the W-Beijing family are similar and overwhelmingly induced during Mtb infections, collectively typifying
a robust gene expression signature (‘‘THP1r2Mtb-induced signature’’). Analysis of the putative transcription factor binding
sites in promoter regions of genes in this signature identified several key regulators, namely STATs, IRF-1, IRF-7, and Oct-1,
commonly involved in interferon-related immune responses. The THP1r2Mtb-induced signature appeared to be highly
relevant to the interferon-inducible signature recently reported in active pulmonary tuberculosis patients, as revealed by
cross-signature and cross-module comparisons. Further analysis of the publicly available transcriptome data from human
patients showed that the signature appears to be relevant to active pulmonary tuberculosis patients and their clinical
therapy, and be tuberculosis specific. Thus, our results provide an additional layer of information at the transcriptome level
on mechanisms involved in host macrophage response to Mtb, which may also implicate the robustness of the cellular
defense system that can effectively fight against genetic heterogeneity in this pathogen.
Citation: Wu K, Dong D, Fang H, Levillain F, Jin W, et al. (2012) An Interferon-Related Signature in the Transcriptional Core Response of Human Macrophages to
Mycobacterium tuberculosis Infection. PLoS ONE 7(6): e38367. doi:10.1371/journal.pone.0038367
Editor: Pere-Joan Cardona, Fundacio ´ Institut d’Investigacio ´ en Cie `ncies de la Salut Germans Trias i Pujol - Universitat Auto `noma de Barcelona - CIBERES, Spain
Received December 7, 2011; Accepted May 3, 2012; Published June 4, 2012
Copyright:  2012 Wu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by the European Community (FP7 project TB-VIR, grant no. 200973, and FP6 project TB-ADAPT, grant no. LSHP-CT-
2006-037919). Also, this work was supported in part by National Natural Science Foundation Grants of China (90919059, 30730033, 31171257, 30971623,a n d
81170503), Chinese Academy of Sciences (KSCX1-YW-22-01, and KSCX2-EW-Q-1-08), Ministry of Science and Technology of China (2009CB825607), and the
Shanghai Commission of Science and Technology (09410706500), the Centre de la Recherche Scientifique (CNRS) and the Institut Pasteur. ON is a fellow of a
CNRS-ATIP grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: olivier.neyrolles@ipbs.fr (ON); jizhang@sibs.ac.cn (JZ)
. These authors contributed equally to this work.
Introduction
Mycobacterium tuberculosis (Mtb) causes most cases of tuberculosis
(TB) in humans, claiming over 1.5 million lives every year. Mtb
isolates are more genetically diverse than previously thought, and
most interestingly, such Mtb genetic lineages seem to be associated
with bio-geographic human populations [1–3]. For convenience,
Mtb lineages are thus named after their geographic origins. One
group of such genetically related Mtb isolates was first reported
from patients mainly from Beijing, China, and hence was named
as ‘‘Beijing family’’ of Mtb strains [4]. At the same time period,
‘‘W’’ strains were described in New York City, USA [5], and
exhibited relatedness with strains of the Beijing family [6]. These
two strain families were then collectively named as ‘‘W-Beijing’’.
Since first described, the W-Beijing family has raised increasing
concerns globally. Indeed W-Beijing strains of Mtb account for up
to 50% of TB cases in East-Asia (nearly 13% in the world);
moreover, several lines of evidences have pointed to their higher
virulence, as compared to other strains, in various in vitro and in vivo
models [4]. For instance, strains of the W-Beijing family resulted in
more bacilli in the lung and earlier mortality of experimentally
infected mice, as compared with strains from other families
including Somali, Haarlem, Canetti, and the laboratory stain
H37Rv [7], as well as in higher bacilli load in the cerebrospinal
fluid and brain, and more severe clinical manifestations in rabbit
model of tuberculosis meningitis, as compared to the clinical strain
CDC1551 [8]. Other studies have shown that strains of the W-
Beijing family induced less protective cytokines but more cell
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phage-like THP-1 cells, as compared to H37Rv [9,10].
Here we aimed at exploring host macrophage response to
Mtb W-Beijing on a genome-wide scale using gene expression
profiling. Transcriptome profiling has been widely used to gain
insights into host-mycobacteria interactions in various contexts
[11]. In this study, we used the human macrophage-like THP-1
cell line as a model of innate immune cell because it allows to
minimize the influence of host heterogeneity as compared to
human blood donor-derived primary macrophages [12]. In
addition to the reference laboratory strain H37Rv, a total of
eleven Mtb strains representing six sublineages of the W-Beijing
family (Figure 1) were used to infect host cells, and were
subsequently profiled using whole-genome expression arrays.
Through detailed data mining, we found transcriptome
responses of the host were largely similar, irrespective of the
Mtb W-Beijing subgroups tested, although it could not be
excluded that there were minor differences between different
strains. Accordingly, a core response gene signature was
recognized (THP1r2Mtb-induced signature). Based on this gene
signature and cross-study comparisons, we were able to identify
several putative immunity-related, and more particularly inter-
feron-related, transcription factors that might regulate the core
host transcriptional response. We were also able to show the
clinical relevance of such core responses with those observed in
active pulmonary tuberculosis patients [13], which appears to be
tuberculosis specific when compared to patients from other
inflammatory diseases and pathological conditions [14,15].
These results provide new insights into the host-pathogen
cross-talk in Mtb infections.
Results
The Transcriptome Responses of THP-1 Cells to Mtb W-
Beijing and H37Rv Strains are Broadly Similar
In our recent work [16], we have used SNPs-based genotyping
to characterize the genetic diversity of Mtb strains of the W-Beijing
family. However, it remains unknown how host cells cope with the
heterogeneity of these SNPs-genotyped strains. In an attempt to
address this issue, we selected eleven W-Beijing strains from the six
most representative sublineages (Figure 1), and these strains, in
addition to H37Rv, were used to infect THP-1 host cells in a time-
series setting. Using whole-genome expression arrays, we per-
formed transcriptome profilings of THP-1 cells infected at three
time points including early stage (4 h), intermediate stage (18 h),
and late stage (48 h), as well as an uninfected sample (0 h) as a
control. After array hybridization and data normalization, Absent-
Present based filtering [12] was applied to select the most reliable
probesets/transcripts. A total of 18,541 transcripts across the 39
infected samples (3 time points 611 Mtb W-Beijing strains, 3 time
points 62 duplicated Mtb H37Rv strain, compared to the
uninfected THP-1 cells as a control) remained and were
subsequently used for unsupervised sample classifications. As
shown in Figure 2A and Figure S1, samples were unambiguously
classified into three groups, exactly corresponding to the infection
time points, and independently of the strain genotype (i.e. H37Rv
vs. W-Beijing, and among W-Beijing sublineages). When compo-
nent plane presentations integrated self-organizing map (CPP-
SOM) [17] were used to illustrate sample-specific transcriptome
map, host cells infected by strains of different genotypes appeared
to share similar global expression changes at each of all three
infection time points (Figure 2B; see also pair-wise correlation
coefficients in Figure S2). Moreover, the major changes were
Figure 1. Experimental design for detecting host transcriptional responses to different Mtb W-Beijing strains. Genetic diversity of W-
Beijing family strains, as revealed by SNPs-based genotyping (see our recent work [16] for details). In brief, 48 SNPs were characterized by sequencing
22 genes (being involved in DNA repair, replication, and recombination) in 58 W-Beijing isolates plus one non-W-Beijing isolate (Myc2). Each node
represents one genotype (the same SNPs profile), with the node area proportional to the population size (the number of W-Beijing isolates in it was
indicated on the left). Strains from the corresponding node used for the THP-1 infection in this study (e.g., R1.4 from Bmyc10) were indicated on the
right. Lab strain H37Rv, which was also recruited for the THP-1 infection, was not shown here.
doi:10.1371/journal.pone.0038367.g001
An Interferon-Related Signature to Mtb Strains
PLoS ONE | www.plosone.org 2 June 2012 | Volume 7 | Issue 6 | e38367observed at the interval between 4 h and 18 h of infection, while
little changes occurred thereafter. These observations suggested
that host transcriptome responses do not rely on the genotype (i.e.
sublineage) of the W-Beijing strains tested. To evaluate the
possibility of whether the genetic diversity of the strains could
instead be explained by function-specific differences in host cells,
we also performed the sample classifications with the same
parameters to Figure 2A but using genes only annotated to specific
functional categories (i.e., immunity and defense from PANTHER
classification system [18]). Like the results shown in Figure 2A,
samples were again grouped together according to the infection
duration, irrespective of the genotype of the strains (Figure S3).
Further restriction using more specific immunity-related processes
did not change the sample relationships (data not shown). In all,
the host transcriptome responses induced by H37Rv and by
different sublineages of Mtb W-Beijing strains are predominantly
similar, and hardly broad differences as well as immune response-
specific differences were detectable, even though we can not
guarantee that minor differences would be observed if more
biological replicates were involved. Although the small number of
strains of each genotype used here may be insufficient to
distinguish subtle genotype- and subgenotype-specific host cell
responses, our results nevertheless suggested that a transcriptional
core response of human macrophages to Mtb infection could be
extracted from our data.
Identification of a Common Host Transcriptome
Response Signature and its Underlying Putative
Transcriptional Regulators
Since host transcriptome responses to Mtb were dramatically
modulated between 4 h and 18 h, regardless of the W-Beijing
sublineages (Figure 2), we next aimed to study the core responses
between these two time points. It was also appealing to speculate
that there might exist a common host transcriptome response
signature, reflective of the robust nature of host cellular responses.
To validate this speculation, we applied a LIMMA-based
methodology [19] to identify genes differentially expressed
between 4 h and 18 h. These genes were collectively informative
as a common THP-1 response to Mtb (THP1r2Mtb; Table S2). As
showed in Figure 3A, the THP1r2Mtb could be further divided
into two parts: one for the induction at 18 h (and 48 h) as
compared with 4 h (THP1r2Mtb-induced), the other for the
repression (THP1r2Mtb-repressed). Interestingly, as high as 92%
(367/399) of genes in the THP1r2Mtb are generally induced (i.e.,
THP1r2Mtb-induced). When enrichment analysis was applied to
examine whether they shared functional or regulatory features
[20] (see below for details), we only observed biological features
associated with genes in the THP1r2Mtb-induced (Figures 3B–
3D), and in contrast, neither functional terms nor transcription
factors were significantly linked to genes in the THP1r2Mtb-
repressed. Since genes in the THP1r2Mtb-repressed were trivial
both in number and functional/regulatory relevance, we only
considered the THP1r2Mtb-induced group of genes, and the latter
was therefore denoted as the common host transcriptome response
signature (hereinafter referred to as ‘‘THP1r2Mtb-induced signa-
ture’’) for the subsequent analysis.
As shown in Figure 3B, functional enrichment analysis using
Gene Ontology (GO) [20,21] suggested that genes in the signature
were related to cellular immune responses and defenses. Consis-
tent with this finding, the most significant KEGG pathway [21]
was only associated with cytokine-cytokine receptor interaction
(Figure 3C). Most of the genes involved in the cytokine-cytokine
receptor interaction have functional implications mediating host-
pathogen cross-talk involving Mtb (Figure S4). For instance, CCR7
[22], CXCL13 [23], CCL2 [24], and IL15 [25] have been reported
to be involved in the adaptive immunity to Mtb infection. Among
potential clinical signatures reported are CXCL9 [26], CXCL10
[27], CCL1 [28], and IL11 [29], as their expression levels could
differentiate some kinds of clinical manifestations such as latent
TB, pulmonary, and meningeal TB. Indeed, we independently
validated several randomly selected genes (i.e. CXCL10, CXCL11,
TNFSF10, IL15, and CCL8; Figure 3C) by quantitative RT-PCR
(qRT-PCR), showing that these genes were all induced in five Mtb-
infected samples (Figure S5).
In keeping with functional features, we also observed that the
most significant TFBSs (represented in the form of PWMs) are
(putative) immunity-related transcriptional regulators, including
IFN-stimulated response element (ISRE), interferon regulatory
factor 1 (IRF-1), IRF-7, and Oct-1 (also called POU2F1, POU
class 2 homebox 1) (Figure 3D; see also the right panel of
Figure 3A). Several lines of clues have pointed to their involvement
in regulating the immune responses against Mtb infection. First,
literature mining showed that these regulators had been linked to
Mtb in several studies. Two members of the IRF family, namely
IRF-1 and IRF-7, have been reported to be activated in Mtb-
infected human monocyte-derived dendritic cells [30]. Moreover,
the activation of STAT-1/2 is prerequisite for the induction of
IRF-1 and IRF-7 [31]. Oct-1, a member of the POU family
proteins containing six classes (POU1 to POU6), was reported to
regulate type I interferon transcription [32], and was also reported
to be induced in Mtb-infected human monocytes [33]. A recent
study showed that Oct-1 may function as an anti-repressive
regulator of those genes involved in immune and inflammatory
responses when being exposed to oxidative stress [34]. Second, we
accordingly observed the induction of STAT-1/2, IRF-1, IRF-7,
and Oct-1 themselves in our host cell model, which could be
independently validated by qRT-PCR method (Figure 4). Then, a
detailed computational survey allowed us to bridge the potential
links between these multiple immune-responsive regulators (i.e.,
STATs, IRF-1, IRF-7, and Oct-1) and the induction of the
cytokine-cytokine receptor interaction (Figure S6). By looking at
the multifaceted TFBS composition in the promoter regions of the
genes involved in cytokine-cytokine receptor interaction, we found
that most of genes harbored at least one of the putative TFBSs of
four regulators (Figure S6A). These regulators might cooperate in
an additive/synergistic manner to modulate the cytokine-cytokine
receptor interaction, particularly in the interferon pathways
(Figure S6B).
Taken together, the above observations suggested that the genes
in the THP1r2Mtb-induced represent a signature spectrum
characteristic of core host transcriptional response to Mtb. The
identified signature spectrum is most likely to be orchestrated by
immune-responsive, interferon-related, transcription factors in-
cluding STATs, IRF-1, IRF-7, and Oct-1.
Cross-signature and Cross-module Comparisons Mirror
the Transcriptional Importance of STATs, IRF-1, and IRF-7
Binding sites enrichment of ISRE, IRF-1, and IRF-7 in the
THP1r2Mtb-induced signature highlighted the importance of
interferons in the host response to Mtb infection. Interferons
function through their cognate receptors, and subsequently
activate homo/heterodimers of STATs [35]. As validated by
qRT-PCR (Figure 5A), one of the interferon-encoding genes
(IFNB1) experienced significant activation during Mtb infection.
Recently, one study [13] reported an interferon-inducible gene
signature (393 transcripts representing 307 unique Entrez Genes)
in active pulmonary TB (PTB) patients specifically. As shown in
Figure 5B, we found this active PTB signature significantly
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Entrez Genes; P,10
25, Fisher’s exact test). Interferon-inducible
genes, such as GBP1, GBP2, IFIT2, IFIT3, IFITM1, IFI44, IFI44L,
IFIT5, and IFIH1 [13,36], were largely represented in overlapping
genes. In addition, regulatory enrichment analysis showed that
ISRE (corrected P-value: 1.05610
29), IRF-7 (corrected P-value:
9.23610
28), and IRF-1 (corrected P-value: 7.88610
24) were also
overrepresented in this active PTB-correlated whole-blood tran-
script signature (Figure 5C). To further explore the relatedness of
our identified THP1r2Mtb-induced signature to the interferon
response in an unbiased manner, we chose a series of gene
modules that were constructed by a modular-based data-mining
method [15]. Genes in each of these modules were coordinately
expressed across one or more diseases and were associated with
certain functional characteristics. Through comparison, we found
that two modules, M2.10 and M3.1, largely overlapped with our
THP1r2Mtb-induced signature (Figure 5D). Although no general
functions in module M2.10 have been assigned yet, literature
profiling [37] had shown that those genes in M2.10 are as
expected in the case of myeloid cells, such as THP-1 cells, infected
with an inflammatory pathogen, such as Mtb. Module M3.1 is an
interferon-relevant module, in which approximately half of the
genes can be found in the THP1r2Mtb-induced signature.
Regulatory enrichment analysis of the Module M3.1 also
suggested its potential regulation by ISRE (corrected P-value:
3.29610
215), IRF-7 (corrected P-value: 1.55610
219), and IRF-1
(corrected P-value: 2.12610
24) (Figure 5E). These comparative
analyses provide another layer of support for the regulatory
Figure 2. Transcriptome classification of THP-1 cells to W-Beijing strains as well as the lab strain H37Rv. (A) Sample classification of
THP-1 transcriptome responses to Mtb W-Beijing and H37Rv strains.W-Beijing strains from the same node (see Figure 1) were highlighted by the same
color. For example, two CHN50 strains (CHN50.1 and CHN50.2) from node Bmyc26 were colored in black. (B) Component plane presentation
integrated self-organizing map (CPP-SOM) of host transcriptomic responses to 11 different W-Beijing family strains as well as duplicated H37Rv
(columns) at 3 time points (rows). Each presentation illustrates a sample- and time-specific transcriptome map, in which all the up-regulated
(represented by neurons in red), down-regulated (represented by neurons in blue) and moderately regulated (represented by neurons in yellow and
green) genes were well delineated. Linking these presentations allows visual-easy comparisons of transcriptome changes across time points and
strains.
doi:10.1371/journal.pone.0038367.g002
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Mtb infection.
The THP1r2Mtb-induced Signature can be Used as a
General Indicator Distinguishing Human Tuberculosis
Patients of Different Disease Degrees and of Different
Therapy Periods, and Appears to be Tuberculosis Specific
Since the THP1r2Mtb-induced signature reflects common
immune responses to Mtb infection, both in terms of functional
and regulatory relevance, we therefore further explored the
possibility of using this signature to monitor the human
tuberculosis patients with different extent of the disease. To do
so, we viewed the signature as a gene set for gene set enrichment
analysis (GSEA) [38] using the blood transcriptome data from
human tuberculosis patients [13] (see Materials and Methods). As
shown in Table 1 (also see Figure S7), the THP1r2Mtb-induced
signature was significantly and positively correlated with the active
pulmonary TB (PTB) as compared to latent TB (LTB) and healthy
controls (Con), using any of the three datasets including London
patient-based training set, London patient-based test set and South
Africa patient-based validation set. When the separate cell sets
were used in which bloods in PTB were separated into neutrophils,
monocytes, CD4
+ and CD8
+ T cells, significant positive correla-
tions were also observed (Table 1 and Figure S8), with the most
positive for neutrophils (Neut_PTB vs. Neut_Con with NES=3.27
and FDR=0). This is consistent with the fact that neutrophils
account for the largest white cell population in blood compared to
the other three (i.e., monocytes, CD4
+ T cells, CD8
+ T cells) [13].
In addition to the correlation with the human tuberculosis
patients, we found that the THP1r2Mtb-induced signature was
also relevant to the PTB therapy as well (Table 1 and Figure S9).
GSEA analyses of the signature using longitudinal study showed
that, compared to the healthy control, the positive correlation
decreased gradually as the therapy was prolonged from the pre-
therapy (PTB_0m vs. Con with NES=2.95 and FDR=0) to 2-
month therapy (PTB_2m vs. Con with NES=2.62 and FDR=0)
and to 12 months after the therapy (PTB_12m vs. Con with
NES=1.43 and FDR=0). Although the significant positive
correlations were still observed for both PTB_2m and PTB_12m
against the healthy control, significant negative correlations were
instead observed when the comparisons were made against the
pre-therapy PTB (PTB_2m vs. PTB_0m with NES=22.08 and
FDR=0; PTB_12m vs. PTB_0m with NES=22.96 and
FDR=0). These results clearly showcase the discriminative power
of the THP1r2Mtb-induced signature in distinguishing human
tuberculosis patients of different disease degrees and of different
therapy periods.
Figure 3. A common host transcriptome response signature and its biological characteristics. (A) Illustration of expression patterns of
differentially expressed genes (THP1r2Mtb) between 4 h to 18 h after Mtb infection. Those genes induced are most prominent, thus representing a
common host transcriptome response signature spectrum. Genes whose promoter regions (2,000 bp upstream to 200 bp downstream of
transcription start site) harbouring the putative TFBSs obtained from Expander [53] were indicated by bars in blue. (B, C, and D) Significant functional
and regulatory features in the THP1r2Mtb-induced signature, including GO for functional enrichments, KEGG for pathway enrichments and positional
weighted matrix (PWM) for regulatory enrichments. Also listed underneath in Figure 3C are genes involved in the cytokine-cytokine receptor
interaction, wherein those independently validated by qRT-PCR were highlighted in bold (see also Figure S5).
doi:10.1371/journal.pone.0038367.g003
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extensive investigations and detailed evaluations of whether this
signature is Mtb specific. For such a purpose, we selected two
transcriptome datasets of peripheral-blood mononuclear cells,
which were isolated from human patients with other inflammatory
diseases and pathological conditions [14,15], and used them for
the GSEA analysis of the THP1r2Mtb-induced signature. As
showed in Table 2, no correlation was observed between this
signature and any of acute infections caused by Streptococcus
pneumoniae (Strep), Staphylococcus aureus (Staph), Influenza A, and E. coli
[14] (see also Figure S11). Similarly, we also observed no
significant correlation of the signature with any inflammatory
diseases and pathological conditions reported in [15] (Table 3 and
Figure S13), including type I diabetes, Staph infection, liver
transplant undergoing immunosuppressive therapy, E. coli infec-
tion, metastatic melanoma, systemic lupus erythematosus (SLE),
and systemic juvenile idiopathic arthritis (JIA). These observations
suggest that the THP1r2Mtb-induced signature might be specific
to Mtb. This preliminary analysis also indicates the worth of future
studies in further clarifying the Mtb-specific nature of our identified
signature (and its derivatives) to justify its potential value in the
clinical settings.
Discussion
The Robust Nature of Immune Cells in Responding to
Mtb
How immune cells cope with the heterogeneous nature of a
pathogen is key to understand host-pathogen cross-talk. Using
THP-1 cells as a host immune cell system, we have profiled
time-course host transcriptome responses to distinct Mtb strains
of the W-Beijing family. Although these strains show genetic
diversity (Figure 1), surprisingly these differences were largely
ignored by immune cells in terms of transcriptional responses
(Figure 2). To exclude the possibility that the effects of genetic
diversity on the host were caused by functional biases, we have
restricted our analysis based on specific functional categories
and found the sample relationships were robustly preserved
(Figure S3). More importantly, this genome-wide expression
resource provides useful clues for understanding the ability of
host cells to respond to this genetically diversified pathogen.
From the temporal point of view, THP-1 cells after 4 h of
infection did not exhibit obvious changes at the transcriptional
level. From 4 h to 18 h, dramatic transcriptional changes
occurred. Thereafter, this state of transcriptome lasted to 48 h
(Figure 2), after which host cells underwent extensive death.
With contrast to transcriptomes at 4 h (the early phase of THP-
1 response), the transcriptomes at 18 h and 48 h represent
balanced states between THP-1 cells and Mtb strains. From the
epidemiological point of view, different groups of strains within
W-Beijing family are known to have different transmissibility
[16,39,40]. This different transmissibility may rely on their
differential ability to modify the host immune response (both
innate and adaptive immunity). However, we have shown that
host transcriptional responses, at least in THP-1 cells, are not
sensitive to the strain-to-strain variability. This is consistent with
our recent report showing that cytokine secretion by human
primary macrophages and dendritic cells was unaffected by the
genetic diversity within the W-Beijing family [41]. The temporal
duration of infections dwarfs genetic diversity of strains, which
highly suggests the robustness of host cells to invasions from this
evolving pathogen.
The Potential Regulatory Mechanisms Underlying the
Robustness of Host Cell Responses to Mtb
Time-specific and genotype-irrelevant host transcriptome
responses have allowed us to identify a common signature of
host responses during the shift from 4 h to 18 h (Figure 3).
Using the concept of reverse engineering, functional and
regulatory features have been inferred from this signature. We
have observed that most of the genes in this signature are of
functional relevance to immune-related processes and pathways,
indicating rigorous activation of the immune response. It has
been known for over a decade that immune cells, in particular
phagocytes such as macrophages and dendritic cells, exhibit a
core gene expression profile when exposed to various microor-
ganisms, even from diverse phyla [42,43]. The core of immune-
related genes found here in Mtb-infected THP-1 cells is
consistent with previous reports in other phagocytes
[12,14,44,45]. Based on computationally predicted TFBSs, we
have also identified several transcription factors (i.e., STATs,
IRF-1, IRF-7, and Oct-1); the induction of both their putative
targeted genes and their own may be largely responsible for the
observed common host responses (Figures 3 and 4). Interest-
ingly, transcriptional regulators such as NF-kB [46], which are
commonly believed to be pivotal in the immune response
against pathogen, were not over-represented in genes signifi-
cantly regulated at 18 h compared to 4 h. This is likely because
the NF-kB (and genes influenced by this master regulator) might
be involved before 18 h and thus we were not able to capture
such involvement. Alternatively, transcriptional regulators iden-
tified in this study might compensate the absence of NF-kB. In
the future, follow-up studies may be needed to clarify its exact
regulatory roles.
The potential involvement of the immune-relevant transcrip-
tional regulators in common host transcriptional responses has
several important implications. First, STATs, IRF-1, IRF-7, and
Oct-1 highlight the importance of interferons in host response to
Mtb-infection. Indeed, one of the interferon-encoding genes
(IFNB1) displays significant activation in our data (Figure 5A).
Further comparison with a clinical patient-linked signature and
Figure 4. qRT-PCR validation of transcriptional regulators
STAT-1/2, IRF-1, IRF-7, and Oct-1. Data were obtained from four
time-series samples infected by strains of R1.4, ZA9.2, R17.1, and
MAD2.1. Fold changes of the induction were illustrated and statistic
tests were performed. ** for P-value,0.01.
doi:10.1371/journal.pone.0038367.g004
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interferon-inducible genes and their putative regulators STATs,
IRF-1, and IRF-7 (Figures 5B–5E). Second, enrichment of Oct-1
binding site also implies its regulatory importance in the host
response to Mtb infection. Probably, Oct-1 cooperates with other
regulators to form a regulatory network. In addition to our host
model, two in vitro studies have previously reported the simulta-
neous activation of STATs, IRF-1, IRF-7, and Oct-1 after
infection of human monocytes or dendritic cells by Mtb strains
[31,33]. Third, our preliminary analysis suggests the mechanistic
links between immune-relevant transcriptional regulators and the
cytokine-cytokine receptor interaction (Figure S6). We suspect that
the modulation of genes involved in the cytokine-cytokine receptor
interaction by these regulators, probably in an additive/synergistic
manner, may underpin the robustness of host cell responses to Mtb
W-Beijing strains.
Perspectives on Future Studies of Host Transcriptional
Responses to Mtb Pathogens
In additional to W-Beijing family strains, we have also profiled
transcriptomic responses of THP-1 cells to the laboratory strain
H37Rv. We observed no obvious host transcriptome differences
between cells infected with W-Beijing strains and with H37Rv. No
matter their origins, samples are generally grouped together
according to the infection duration (Figures 2A, S1, and S3). This
observation needs further clarification involving more samples in
future studies. Since this study has revealed the commonality of the
host cell response to infection by different W-Beijing strains, it is
also needed to investigate whether the host immune system
responds in a similar or different way, upon infections of different
strains from non-W-Beijing families.
We expect that, in the near future, the TB community could
benefit from the use of the signature identified in this study.
Figure 5. Transcriptional importance of STATs, IRF-1, and IRF-7 as supported by cross-signature and cross-module comparisons. (A)
qRT-PCR validation of IFNB1 induction. Data were from samples as in Figure 4. ** for P-value,0.01. (B) Gene overlap of the THP1r2Mtb-induced
signature and an active pulmonary TB (PTB) signature [13]. (C) Regulatory/TFBS enrichment analysis in promoter regions of the active PTB signature
in the form of PWM. (D) Gene overlap analysis of predefined modules and the THP1r2Mtb-induced signature. Only those modules with more than
10% of genes (represented by the proportion of black area in the pie) presented in the THP1r2Mtb-induced signature were displayed. Functional
interpretations of modules through literature profiling [15] were indicated at lower panel. (E) Regulatory/TFBS enrichment analysis of module M3.1.
doi:10.1371/journal.pone.0038367.g005
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practically only some of them should be taken as a priority. Based
on their expertise and experimental convenience, researchers
might only show interests in some genes for detailed functional
studies. In particular, those genes involved in cytokine-cytokine
interactions should be the focus of future studies for their clinical
value as prognosis and diagnosis. Although currently we are
tempted to these small-scale studies, we are always encouraged by
signature-based microarray analysis of human TB patients once
the techniques allow us to do so, both scientifically reliable and
financially feasible.
In this setting, we have also shown that this in vitro THP-1 host
cell model has great relevance to clinical tuberculosis. Processing
transcriptome data from human tuberculosis patients, we have
illustrated that the identified common host response signature is
positively correlated with the PTB patients, no matter whether the
patients were recruited from intermediate (UK) or high-burden
(Sough Africa) regions (Table 1) [13], and accordingly is also
correlated with patients of different therapy periods. Furthermore,
we illustrated that the THP1r2Mtb-induced signature is tubercu-
losis specific and is irrelevant to human patients with other
inflammatory diseases and pathological conditions (Tables 2 and
3). For these reasons and because of this signature potentially
regulated by STATs, IRF-1, IRF-7, and Oct-1, we anticipate that
establishing genome-wide links among these predicted regulators
through high-throughput approaches (e.g. ChIP-seq [47]) might
not only extend the knowledge we obtained from this study, but
also allow us to explore their clinical value in the future.
Materials and Methods
Mtb Strains, Cell Line and Infection
Strains were grown at 37uC in Middlebrook 7H9 broth (BD
Difco) supplemented with 10% albumin-dextrose-catalase
(ADC), 0.5% glycerol and 0.05% tween-80. THP-1 cell line,
which was obtained from cell bank of Chinese Academy of
Sciences (Shanghai, China), was maintained at 37uCi n5 %
CO2 in RPMI 1640 (Gibco) supplemented with 10% FBS. Prior
to infection, THP-1 cells were induced to differentiate into
macrophages with 200 nM PMA (Sigma) for 24 h. Then, THP-
1 cells were infected at multiplicities of infection (MOI) of 5.
After 4, 18 and 48 h, the infected cells were collected for each
of 11 Mtb W-Beijing strains. Also, THP-1 cells were infected by
the reference laboratory strain H37Rv, and the infected cells at
4, 18, and 48 h were collected (in duplicate). A total of 40
samples (including the 33 W-Beijing-infected samples, the 6
H37Rv-infected samples, and an uninfected sample at 0 h as a
Table 1. GSEA of the THP1r2Mtb-induced signature using
transcriptome data from human tuberculosis patients.
Cohort
1
Group
comparison
2 NES
3 FDR
4 Correlation
4
Training set PTB vs. Con 3.23 0.000 Positive
PTB vs. LTB 3.00 0.000 Positive
LTB vs. Con 21.22 0.071 Null
Test set PTB vs. Con 3.46 0.000 Positive
PTB vs. LTB 3.12 0.000 Positive
LTB vs. Con 2.37 0.000 Positive
Validation set PTB vs. LTB 3.27 0.000 Positive
Test set_seperated Neut_PTB vs.
Neut_Con
3.27 0.000 Positive
Mono_PTB vs.
Mono_Con
2.98 0.000 Positive
CD4_PTB vs.
CD4_Con
1.86 0.000 Positive
CD8_PTB vs.
CD8_Con
1.70 0.000 Positive
Longitudinal study PTB_0m vs. Con 2.95 0.000 Positive
PTB_2m vs. Con 2.62 0.000 Positive
PTB_12m vs. Con 1.43 0.000 Positive
PTB_12m vs.
PTB_0m
22.96 0.000 Negative
PTB_2m vs.
PTB_0m
22.08 0.000 Negative
1Traning set: all the donors, which were defined as PTB, LTB or healthy, were
recruited from London, UK. Test set: all the donors were from London UK.
Validation set: all the donors were from Cape Town, South Africa. Test
set_seperated: purified neutrophils, monocytes, CD4
+ T cells, and CD8
+ T cells
from both PTB and healthy controls. Longitudinal study: PTB patients before
drug treatment, 2 months after drug treatment, and 12 months after drug
treatment.
2Group-group contrasted and ranked by LIMMA-based method.
3(+) NES for positive correlation, (2) NES for negative correlation.
4Significance of correlation, an FDR of 0.05 or lower was accepted as statistically
significant for NES (‘‘Positive’’ or ‘‘Negative’’), otherwise ‘‘Null’’. See Figures
S7,S8,S9 for plot graph of each group comparison. See Figure S10 for CPP-SOM
graph of expression data of each donor.
doi:10.1371/journal.pone.0038367.t001
Table 2. GSEA of the THP1r2Mtb-induced signature using
transcriptome data from human patients with acute
infections.
Group comparison
1 NES
2 FDR
3 Correlation
3
Strep vs. Con 20.58 1.00 Null
Staph vs. Con 20.77 0.87 Null
Influenza A vs. Con 20.88 0.69 Null
E. coli vs. Con 20.65 0.96 Null
1Strep: Streptococcus pneumonia infection, Staph: Staphylococcus aureus
infection.
2,3The same as in Table 1.
doi:10.1371/journal.pone.0038367.t002
Table 3. GSEA of the THP1r2Mtb-induced signature using
transcriptomes from patients with other inflammatory or
pathological conditions.
Group comparison
1 NES
2 FDR
3 Correlation
3
Type I diabetes vs. Con 21.34 0.112 Null
Staph vs. Con 21.09 0.305 Null
Liver-transplant vs. Con 20.79 0.892 Null
E. coli vs. Con 20.91 0.646 Null
Melanoma vs. Con 20.91 0.641 Null
SLE vs. Con 21.14 0.396 Null
JIA vs. Con 20.74 1.000 Null
1Staph: Staphylococcus aureus infection, Liver-transplant: liver-transplant
undergoing immunosuppressive therapy, Melanoma: metastatic melanoma,
SLE: systemic lupus erythematosus, JIA: systemic juvenile idiopathic arthritis.
2,3The same as in Table 1.
doi:10.1371/journal.pone.0038367.t003
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hybridization.
Microarray Hybridization and Data Mining
RNA was treated for hybridization with HG-U133 Plus 2.0
Array according to the Affymetrix protocol. Then, arrays were
scanned by a high-resolution scanner and the scanned images were
converted to cell intensity file (.CEL files) using GeneChip
Operating Software (GCOS). CEL raw expression data were
normalized and filtered as previously described [12]. Briefly, these
CEL raw expression data were first normalized using Robust
Multi-array Averaging (RMA) with quantile normalization in R
(Bioconductor) [19]. Detection call-based filter was then applied to
remove all the probesets whose expression values were consistently
below an empirically determined value of minimum sensitivity.
This value was calculated according to the 95th percentile of all
the ‘Absent’ call-flagged signals of the entire dataset. Any
expression values below this value are considered as being
technically unreliable. Since the uninfected sample was served as
a common control for the comparison, probesets with expression
values less than this empirical value at the uninfected control were
also removed. Finally, expression values of probesets in 39 infected
samples were subtracted by their cognate values in the uninfected
control (0 h).
After the normalization and pre-filtering above, a gene
expression matrix (see Table S1) was constructed, containing
18,541 probesets (representing 10,315 unique Entrez Genes)
across 39 samples, that is, time-courses (4 h, 18 h, and 48 h) of
THP-1 cells infected by each of 11 Mtb W-Beijing strains as
well as H37Rv (in duplicate). This matrix was first subjected to
Cluster3.0 [48]/TreeView-1.0.8 [49] with Euclidean distance for
unsupervised sample classification. The pair-wise Pearson’s
correlation coefficients were also calculated to show a high
degree of similarity for different strains within the same time
point. For gene clustering and visualization, the gene expression
matrix was also subjected to component plane presentation
integrated self-organizing map (CPP-SOM) [17], a component
of topology-preserving selection and clustering (TPSC) package
[50]. Specifically, the input data were first trained using the
SOM algorithm with the Epanechikov neighborhood kernel.
The trained map was then visualized by CPP to display sample-
specific transcriptome changes.
Linear Models for Microarray Data (LIMMA) [19,51] was
applied to identify those differentially expressed genes between any
two successive time points. LIMMA used linear models and
empirical Bayes methods (the moderated t-statistic) in assessing
differential expression. The criteria for identifying the top
significant probesets for the designed contrast was based on
adjusted P-value,0.01, as corrected using Benjamini and Hoch-
berg procedure [19,51]. Under such criteria, all genes identified as
being differentially expressed from 4 h to 18 h were expressed by
2-folds or more. These highly modulated genes were further
divided into two groups: the induced group (THP1r2Mtb-induced)
and the other repressed (THP1r2Mtb-repressed). The former
overwhelmingly dominates the latter; those genes in the
THP1r2Mtb-induced group collectively typify a molecular signa-
ture of common host transcriptome responses to Mtb. Notably,
genes in this signature are not only of statistical significance
(adjusted P-value,0.01), but also of biological significance (at least
2-fold increase from 4 h to 18 h).
Functional and Regulatory Enrichment Analysis
Functional enrichment analysis using Gene Ontology (GO)
and KEGG Pathways was conducted to interpret the gene set of
interest (e.g., those genes in THP1r2Mtb-induced signature).
This analysis was implemented by Database for Annotation,
Visualization and Integrated Discovery (DAVID) v6.7 for
identifying enriched GO and KEGG pathway, based on
Benjamini and Hochberg-derived FDR (,0.01) [21,52]. For
regulatory enrichment analysis, PRomoter Integration in Micro-
array Analysis (PRIMA) was used to identify putative transcrip-
tional regulators for a given gene set compared to background
(entire Entrez Genes) (Bonferroni-corrected P-value,0.01) [53].
Based on the known transcription factor binding sites (as
represented by positional weight matrix, PWM), PRIMA
scanned putative binding sites of promoter sequences spanning
promoter regions from 2,000 bp upstream to 200 bp down-
stream of the transcription start site.
Gene Set Enrichment Analysis (GSEA) of the THP1r2Mtb-
induced Signature against Transcriptome Data from
Human Tuberculosis Patients, and from Human Patients
with other Inflammatory Diseases and Pathological
Conditions
GSEA [38] was applied to determine whether genes in a gene
set (i.e., the THP1r2Mtb-induced signature) show statistically
significant differences between two biological states (such as
tuberculosis patients vs. the healthy controls). Specially, it aimed to
determine the extent to which genes in THP1r2Mtb-induced
signature as a whole were overrepresented at the top or bottom of
a predefined list of ranked genes (derived from publicly available
transcriptome datasets). Three transcriptome datasets were
retrieved from NCBI GEO with accession number GSE19491
[13], GSE6269 [14] and GSE11907 [15] for the GSEA analysis.
In GSE19491, it contains transcriptomes from 498 whole blood
samples that can be subdivided into several cohort sets, including
training set, test set, validation set, longitudinal set, separated cell
set, and others. Here, it was used to test the extent to which the
THP1r2Mtb-induced signature was relevant to active pulmonary
tuberculosis patients and their clinical therapy. As compared to the
corresponding controls, these cohort sets were illustrated by CPP-
SOM into a single visualization (see Figure S10), displaying: 1)
London patients with the active pulmonary TB (PTB) and latent
TB (LTB) for training set, 2) London patients with PTB and LTB
for test set, 3) South Africa PTB for validation set, 4) bloods in
PTB being separated into neutrophils (Neut_PTB), monocytes
(Mono_PTB), CD4
+ (CD4_PTB) and CD8
+ (CD8_PTB) T cells
for separated cell set, 5) PTB at pre-treatment (PTB_0m), 2
months after treatment initiation (PTB_2m), and 12 months after
treatment initiation (PTB_12m).
In additional, another two datasets (GSE6269 and GSE11907),
which were generated by Affymetrix HG-U133A Array platform,
were also used to test whether the THP1r2Mtb-induced signature
was relevant to human patients with other inflammatory diseases
and pathological conditions. In GSE6269, it contains transcrip-
tomes from 97 peripheral-blood mononuclear cell (PBMC)
samples, of which the pediatric donors had the following
conditions/acute infections: 1) E. coli infection, 2) Influenza A
infection, 3) Staphylococcus aureus (Staph) infection, and 4) Streptococcus
pneumonia (Strep) infection. The donor-specific profiles, as compared
to the healthy donors, were visualized by CPP-SOM (see Figure
S12). In GSE11907, it contains transcriptomes from 304 PBMC
samples, of which the donors belonged to one of the following
groups: 1) E. coli infection, 2) Systemic juvenile idiopathic arthritis
(JIA), 3) Systemic lupus erythematosus (SLE), 4) Liver-transplant
recipients undergoing immunosuppressive therapy, 5) Metastatic
melanoma, 6) Type I diabetes, 7) Staphylococcus aureus (Staph)
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profiles were visualized in Figure S14.
For each group comparison above, a list of ranked genes was
predefined by LIMMA supervised analysis, followed by GSEA of
THP1r2Mtb-induced signature. GSEA reported a normalized
enrichment score (NES) and a false discovery rate (FDR) for
interpreting the results. NES reflects the enrichment pattern of a
gene set in a ranked list of genes; positive NES means its
enrichment at the top, and negative one at the bottom. The
significance of NES can be accessed by the FDR. GSEA results
(i.e., NES and FDR) were detailed in Figures S7,S8,S9, S11, and
S13. An FDR of 0.05 or lower was accepted as indicating statistical
significance for NES (positive or negative) as a whole. Notably, this
significance is not specific to individual genes but rather in terms of
the whole signature. The full explanations underlying the GSEA
algorithm can be found in the original paper [38].
Quantitative RT-PCR (qRT-PCR) Analysis
qRT-PCR was performed with SYBR Green PCR Master Mix
(TOYOBO) in an ABI 7900HT Sequence Detection System and
analyzed with SDS2.3 Software (Applied Biosystems). 500 ng of
total RNA was reversely transcribed with SuperScript II Reverse
Transcriptase (Invitrogen). Genes for qRT-PCR validation include
CXCL10, CXCL11, TNFSF10, IL15, CCL8, STAT-1, STAT-2, IRF-
1, IRF-7, and Oct-1 with GAPDH as internal control. Primers were
listed in Table S3.
Accession Number
The transcriptome profilings of THP-1 cells infected by 11 W-
Beijing strains and H37Rv (duplicated) have been deposited in
NCBI GEO under accession number GSE29628.
Supporting Information
Figure S1 Principal component analysis of transcrip-
tome of THP-1 cells infected by Mtb strains. Transcrip-
tome profiles of THP-1 cells infected by W-Beijing strains as well
as the lab strain H37Rv at different time points were colored as
indicated. The number of those genes significantly upregulated
and downregulated between any adjacent time points were colored
red and green respectively, as identified using LIMMA.
(TIF)
Figure S2 The visualization of pair-wise correlations
between samples. The colors relate to Pearson’s correlation
coefficient values, with deeper red colors indicating higher
correlations.
(TIF)
Figure S3 Sample classification based on genes anno-
tated to immunity and defense functional categories.
Immunity and defense related genes (1,091 probesets) was used for
unsupervised sample classification. Samples infected by strains
from the same node were indexed with the same color as in
Figure 2A.
(TIF)
Figure S4 The functional implications of cytokine-
cytokine receptor interactions in mediating host-Mtb
cross-talk. Expression pattern (left panel) of genes involved in
cytokine-cytokine receptor interaction and their functional impli-
cations in TB process (right panel).
(TIF)
Figure S5 qRT-PCR validation of CXCL10 (A), CXCL11
(B), TNFSF10 (C), IL15 (D), and CCL8 (E). Expression of five
genes were validated in five time-series samples infected by strains
of R1.4, ZA9.2, R17.1, MAD2.1, and H37Rv. The fold changes at
4 h and 18 h of infection relative to 0 h (prior to infection) were
log2-transformed.
(TIF)
Figure S6 Potential involvement of STATs, IRF-1, IRF-7,
and Oct-1 in cooperatively regulating cytokine-cytokine
receptor interactions. (A) Relative locations of putative
binding sites (ISRE, IRF-1, IRF-7, and Oct-1) in promoter
regions of genes involved in cytokine-cytokine receptor interac-
tions. (B) Putative target overlaps among STATs, IRF-1, IRF-7,
and Oct-1 on genes in pathway of cytokine-cytokine receptor
interactions.
(TIF)
Figure S7 GSEA of the THP1r2Mtb-induced signature
using transcriptome data from tuberculosis patients
with different disease degrees.
(TIF)
Figure S8 GSEA of the THP1r2Mtb-induced signature
using transcriptome data from different cell populations
in PTB patients.
(TIF)
Figure S9 GSEA of the THP1r2Mtb-induced signature
using transcriptome data from tuberculosis patients
with different therapy periods.
(TIF)
Figure S10 CPP-SOM of transcriptome data from
human tuberculosis patients. The Series Matrix File, which
contains expression data of 498 samples, was downloaded from
NCBI GEO (accession number: GSE19491). The expression data
from PTB, PTB with different therapy periods, LTB, or separated
leucocyte populations of PTB were subtracted by their cognate
healthy controls. Then, the subtracted profiles were visualized by
CPP-SOM as in Figure 2B.
(TIF)
Figure S11 GSEA of the THP1r2Mtb-induced signature
using data from human patients with other acute
infections.
(TIF)
Figure S12 CPP-SOM of transcriptome data from
human patients with other acute infections. The raw data
were downloaded from NCBI GEO (accession number:
GSE6269). The data were normalized and filtered in the same
way as our THP-1 transcriptome data. The acute infection data
were subtracted by the healthy controls, and visualized by CPP-
SOM as in Figure 2B.
(TIF)
Figure S13 GSEA of the THP1r2Mtb-induced signature
using transcriptomes from patients with other inflam-
matory or pathological conditions.
(TIF)
Figure S14 CPP-SOM of transcriptome data from
patients with other inflammatory or pathological con-
ditions. The raw data were downloaded from NCBI GEO
(accession number: GSE11907). The data were normalized,
filtered using the same as our THP-1 transcriptome data.
(TIF)
Table S1 TB expression matrix (18541639).
(TXT)
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THP1r2Mtb-induced signature.
(XLS)
Table S3 Primers for real-time quantitative RT-PCR.
(XLS)
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